Literature DB >> 27277085

Low-intensity ultrasound adjuvant therapy: enhancement of doxorubicin-induced cytotoxicity and the acoustic mechanisms involved.

Takashi Kondo1, Toru Yoshida2, Ryohei Ogawa3, Mariame A Hassan3, Yukihiro Furusawa3, Qing-Li Zhao3, Akihiko Watanabe4, Akihiro Morii4, Loreto B Feril5, Katsuro Tachibana5, Hiroshi Kitagawa6, Yoshiaki Tabuchi7, Ichiro Takasaki7, Mohammad H Shehata8, Nobuki Kudo9, Kazuhiro Tsukada2.   

Abstract

PURPOSE: In this study, the effects of low-intensity pulsed ultrasound (LIU) as an adjuvant to doxorubicin (DOX) treatment was further investigated in comparison to hyperthermia as another widely used adjuvant. The effects were compared with respect to cell killing and apoptosis induction in U937 cells. Human primary liver cancer (PLC) cells were also used to evaluate the effects of the combinations. The use of an echo contrast agent was investigated for further enhancement of cytotoxicity. Finally, the acoustic mechanisms involved were investigated.
METHODS: The effects of different treatment regimens on cell viability were determined using the Trypan blue dye-exclusion test. Apoptosis induction was detected by flow cytometry using fluorescein isothiocyanate-annexin V and propidium iodide staining. The mechanistic study involved electron paramagnetic spin trapping for detecting free radical formation as an indicator of the occurrence of inertial cavitation and spectrophotometry for sucrose hydrolysis as an indicator for noncavitational effects.
RESULTS: The combination treatments exerted synergistic effects on cytotoxicity depending on the acoustic conditions used. The use of LIU as an adjuvant to DOX treatment was shown to be superior to the use of hyperthermia as an adjuvant. Moreover, the combination seems to be promising for other cancer types provided that the acoustic conditions are properly selected with respect to drug concentration. The key ultrasound mechanism responsible for the synergism observed was shown to be the production of free radicals by inertial cavitation. Non-cavitational forces were also shown to contribute to the effect.
CONCLUSION: This study is motivating to engage in in vivo research with various cancer types as a step toward clinical applicability and is emphasizing on the importance of developing therapeutic protocols for setting LIU parameters with respect to other therapeutic conditions.

Entities:  

Keywords:  apoptosis; doxorubicin; low-intensity ultrasound

Year:  2009        PMID: 27277085     DOI: 10.1007/s10396-009-0212-8

Source DB:  PubMed          Journal:  J Med Ultrason (2001)        ISSN: 1346-4523            Impact factor:   1.314


  27 in total

1.  Potentiation of cytotoxicity of adriamycin on human ovarian carcinoma cell line 3AO by low-level ultrasound.

Authors:  T Yu; Z Wang; S Jiang
Journal:  Ultrasonics       Date:  2001-06       Impact factor: 2.890

2.  Effects of dissolved gases and an echo contrast agent on ultrasound mediated in vitro gene transfection.

Authors:  Ryohei Ogawa; Takashi Kondo; Hidemi Honda; Qing Li Zhao; Shigekazu Fukuda; Peter Riesz
Journal:  Ultrason Sonochem       Date:  2002-09       Impact factor: 7.491

3.  An echo-contrast agent, Levovist, lowers the ultrasound intensity required to induce apoptosis of human leukemia cells.

Authors:  Hidetaka Ando; Loreto B Feril; Takashi Kondo; Yoshiaki Tabuchi; Ryohei Ogawa; Qing-Li Zhao; Zheng-Guo Cui; Shin-Ichiro Umemura; Hideki Yoshikawa; Takuro Misaki
Journal:  Cancer Lett       Date:  2005-12-27       Impact factor: 8.679

4.  Potentiation of chemotherapy by low-level ultrasound.

Authors:  G H Harrison; E K Balcer-Kubiczek; H A Eddy
Journal:  Int J Radiat Biol       Date:  1991-06       Impact factor: 2.694

5.  Sonodynamically-induced in vitro cell damage enhanced by adriamycin.

Authors:  S Umemura; N Yumita; Y Okano; M Kaneuchi; N Magario; M Ishizaki; K Shimizu; Y Sano; K Umemura; R Nishigaki
Journal:  Cancer Lett       Date:  1997-12-23       Impact factor: 8.679

Review 6.  Doxorubicin (adriamycin): a critical review of free radical-dependent mechanisms of cytotoxicity.

Authors:  H G Keizer; H M Pinedo; G J Schuurhuis; H Joenje
Journal:  Pharmacol Ther       Date:  1990       Impact factor: 12.310

Review 7.  Cancer therapy with ultrasound: a historical review.

Authors:  F W Kremkau
Journal:  J Clin Ultrasound       Date:  1979-08       Impact factor: 0.910

8.  Effects of dissolved gases and an echo contrast agent on apoptosis induced by ultrasound and its mechanism via the mitochondria-caspase pathway.

Authors:  Hidemi Honda; Qing-Li Zhao; Takashi Kondo
Journal:  Ultrasound Med Biol       Date:  2002-05       Impact factor: 2.998

9.  Effects of microbubbles on ultrasound-mediated gene transfer in human prostate cancer PC3 cells: comparison among Levovist, YM454, and MRX-815H.

Authors:  Akihiko Watanabe; Remon Otake; Tetsuo Nozaki; Akihiro Morii; Ryohei Ogawa; Shinichi Fujimoto; Shinobu Nakamura; Hideki Fuse; Takashi Kondo
Journal:  Cancer Lett       Date:  2008-03-07       Impact factor: 8.679

10.  Combination of doxorubicin and low-intensity ultrasound causes a synergistic enhancement in cell killing and an additive enhancement in apoptosis induction in human lymphoma U937 cells.

Authors:  Toru Yoshida; Takashi Kondo; Ryohei Ogawa; Loreto B Feril; Qing-Li Zhao; Akihiko Watanabe; Kazuhiro Tsukada
Journal:  Cancer Chemother Pharmacol       Date:  2007-05-16       Impact factor: 3.333

View more
  5 in total

1.  Differential cytotoxicity and sonosensitization by sanazole: effect of cell type and acoustic parameters.

Authors:  Mariame A Hassan; Yukihiro Furusawa; Qing-Li Zhao; Ichiro Takasaki; Loreto B Feril; Katsuro Tachibana; Nobuki Kudo; Masami Minemura; Toshiro Sugiyama; Takashi Kondo
Journal:  J Med Ultrason (2001)       Date:  2011-01-05       Impact factor: 1.314

2.  Inhibitory effects of low-intensity pulsed ultrasound sonication on the proliferation of osteosarcoma cells.

Authors:  Toshihiro Matsuo; Keiji Sato; Takuya Matsui; Shigeyuki Sawada; Yoshitaka Muramatsu; Katsuhisa Kawanami; Masataka Deie
Journal:  Oncol Lett       Date:  2017-06-23       Impact factor: 2.967

Review 3.  Ultrasound-guided drug delivery in cancer.

Authors:  Sayan Mullick Chowdhury; Taehwa Lee; Jürgen K Willmann
Journal:  Ultrasonography       Date:  2017-05-01

4.  In Vitro Carcinoma Treatment Using Magnetic Nanocarriers under Ultrasound and Magnetic Fields.

Authors:  Somoshree Sengupta; Chandra Khatua; Vamsi K Balla
Journal:  ACS Omega       Date:  2018-05-21

Review 5.  A review on the use of magnetic fields and ultrasound for non-invasive cancer treatment.

Authors:  Somoshree Sengupta; Vamsi K Balla
Journal:  J Adv Res       Date:  2018-06-20       Impact factor: 10.479

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.